Lumexa Imaging Holdings, INC

Lumexa Imaging Holdings, Inc. has amended its existing Credit Agreement, establishing a new secured term loan facility of approximately $823 million and a secured revolving credit facility of $250 million.

Lumexa Imaging Holdings, Inc. successfully concluded its 2026 Annual Meeting, electing three directors and ratifying its independent auditor.

Lumexa Imaging announced its first quarter 2026 financial results, showing a 3.1% increase in consolidated revenues and a return to net income, while reiterating its full-year 2026 financial outlook.

Lumexa Imaging Holdings, Inc. reaffirmed its full-year 2026 financial guidance during a recent meeting and site visit.

Lumexa Imaging announced preliminary Q4 and full year 2025 financial results, showcasing strong Adjusted EBITDA growth and reiterating its 2026 guidance.

Lumexa Imaging Holdings, Inc. announced preliminary unaudited financial results for Q4 and full-year 2025, showing significant revenue and Adjusted EBITDA growth, alongside 2026 guidance.

Lumexa Imaging posted 7.8% revenue growth to $1.023B in 2025, narrowed its net loss to $47.1M, raised $427M in its December IPO, and refinanced debt while flagging material weaknesses in internal controls.

Director Robert Louis Mittl Jr. was granted 19,358 restricted stock units by Lumexa Imaging Holdings, Inc.

Director Matthew Lungren was granted 19,358 restricted stock units in Lumexa Imaging Holdings, Inc. on June 10, 2026.

Director Bridget E. Karlin was granted 19,358 restricted stock units in Lumexa Imaging Holdings, Inc. on June 10, 2026.

Director Molly Joseph was granted 19,358 restricted stock units in Lumexa Imaging Holdings, Inc. on June 10, 2026.

Director Glenn Eisenberg was granted 19,358 restricted stock units in Lumexa Imaging Holdings, Inc. on June 10, 2026.

Director Henry Lee Cooper acquired 19,358 restricted stock units in Lumexa Imaging Holdings, Inc. as part of a standard equity grant.

Lumexa Imaging Holdings, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 10, 2026, to elect directors and ratify auditor appointment.

Welsh, Carson, Anderson & Stowe XII and its affiliates have reported a 74.3% beneficial ownership stake in Lumexa Imaging Holdings, Inc. following its recent IPO.